Related references
Note: Only part of the references are listed.Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study
Fusheng Li et al.
PLOS ONE (2011)
Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC: env molecular clones isolated from infections in China
Suting Wang et al.
VIRUS RESEARCH (2011)
Genotypic and Phenotypic Characterization of HIV-1 CRF01_AE env Molecular Clones From Infections in China
Jianhui Nie et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Vaccinia virus strain differences in cell attachment and entry
Zain Bengali et al.
VIROLOGY (2009)
Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China
Huihui Chong et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
Kaifan Dai et al.
VACCINE (2008)
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
Linda S. Wyatt et al.
VIROLOGY (2008)
The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
Penny L. Moore et al.
JOURNAL OF VIROLOGY (2008)
Immunogenicity comparison between codon optimized HIV-1CRF BC_07 gp140 and gp145 vaccines
Lianxing Liu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays
John E. Kim et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes
Weijun Zhu et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection
Uma Malhotra et al.
JOURNAL OF VIROLOGY (2007)
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay
Sheri Dubey et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to neutralization during clade C infection
Rong Rong et al.
JOURNAL OF VIROLOGY (2007)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
Fusheng Li et al.
VACCINE (2006)
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies
B Peng et al.
JOURNAL OF VIROLOGY (2005)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain
Q Fang et al.
VIROLOGY (2005)
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes
FA Legrand et al.
JOURNAL OF VIROLOGY (2004)
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-Cell activity
PC Reading et al.
JOURNAL OF VIROLOGY (2003)
Immunogenicity and safety of defective vaccinia virus lister:: Comparison with modified vaccinia virus Ankara
BT Ober et al.
JOURNAL OF VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene
J zur Megede et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
